Nanyan Yang
Overview
Explore the profile of Nanyan Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Z, Deng L, Cheng M, Ye X, Yang N, Fan Z, et al.
Int J Oncol
. 2025 Feb;
66(3).
PMID: 39981904
Liver metastasis is the leading cause of colorectal cancer (CRC)‑related mortality. Microbiota dysbiosis serves a role in the pathogenesis of colorectal liver metastases. Bile acids (BAs), cholesterol metabolites synthesized by...
2.
Qian G, Yang N, Deng F, Zhang M, Pan X, Tan B, et al.
Clin Genet
. 2025 Jan;
107(4):402-412.
PMID: 39829082
Intellectual and developmental disabilities (IDD) are clinically and genetically heterogeneous disorders of global concern. While whole exome sequencing (WES) is used to identify single nucleotide variants (SNVs) and small insertions/deletions...
3.
Sun L, Yang N, Liu Z, Ye X, Cheng M, Deng L, et al.
J Biomed Sci
. 2024 Jul;
31(1):66.
PMID: 38951890
Background: Cholestasis is a common yet severe complication that occurs during the advancement of liver metastasis. However, how cholestasis impacts the development, treatment, and tumor microenvironment (TME) of liver metastasis...
4.
Wang L, Liang B, Jiang Y, Huang G, Tang A, Liu Z, et al.
Cancer Med
. 2023 Sep;
12(19):19595-19606.
PMID: 37740601
Background: Studies exploring whether metastatic organotropism and risk in gastric cancer (GC) differ by primary anatomical site are scarce. Methods: This study included 15,260 and 1623 patients diagnosed with GC...
5.
Zheng Y, Zhou R, Cai J, Yang N, Wen Z, Zhang Z, et al.
Cancer Res
. 2023 Aug;
83(21):3577-3592.
PMID: 37610655
Significance: Extracellular matrix stiffening drives bevacizumab resistance by stimulating hepatic stellate cells to provide fuel for mCRC cells in the liver, indicating a potential metabolism-based therapeutic strategy for overcoming resistance.
6.
Wu J, Liu Y, Cao M, Zheng N, Ma H, Ye X, et al.
ACS Appl Mater Interfaces
. 2023 Jan;
15(4):5667-5678.
PMID: 36651290
Hypoxia, as a main feature of the tumor microenvironment, has greatly limited the efficacy of photodynamic therapy (PDT), as well as its clinical application. Here, a multifunctional composite nanoplatform, the...
7.
Sun L, Liu Y, Yang N, Ye X, Liu Z, Wu J, et al.
Acta Biomater
. 2022 Dec;
158:583-598.
PMID: 36586500
Gold nanoparticles (AuNPs) are prospective tools for nano-based medicine that can directly target cellular biological processes to influence cell fate and function. Studies have revealed the essential role of AuNPs...
8.
Li F, Li J, Wang P, Yang N, Huang J, Ou J, et al.
Biochim Biophys Acta Mol Basis Dis
. 2021 Aug;
1867(12):166260.
PMID: 34461258
Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced inflammatory responses are largely responsible for the death of novel coronavirus disease 2019 (COVID-19) patients. However, the mechanism by which SARS-CoV-2 triggers...
9.
Yang N, Liu Z, Pang S, Wu J, Liang J, Sun L
Biochem Biophys Res Commun
. 2020 Dec;
534:157-164.
PMID: 33308825
Renal clear cell carcinoma (ccRCC), is an inflammation-related malignancy with poor therapeutic outcome. Interferon-induced transmembrane protein 2 (IFITM2), an inflammation related gene, is reported to promote tumor progression via inducing...
10.
Li F, Zhao X, Sun R, Ou J, Huang J, Yang N, et al.
J Extracell Vesicles
. 2020 Dec;
10(1):e12003.
PMID: 33304472
Nasopharyngeal carcinoma (NPC) is the most common cancer with high metastatic potential that occurs in the epithelial cells of the nasopharynx. Distant metastases are the primary cause for treatment failure...